News
Electronic Health Records (EHRs) have revolutionized how healthcare providers manage and use patient data, leading to ...
The firms will use nFerence's Agentic AI platform to analyze real-world treatment patterns in 700 patients' charts and inform personalized care.
Columnist Alyssa Silva's medical charts aren't a complete reflection of who she is. That's why she's defining health on her ...
"These programs are having to make very difficult decisions about how to move forward," said Gabrielle de la Guéronnière of ...
Camzyos is an oral, selective allosteric and reversible inhibitor of cardiac myosin. It was approved in April 2022 for the treatment of adults with symptomatic New York Heart Association (NYHA) class ...
More than 2 out of 5 American adults are obese, according to the Centers for Disease Control. With this figure in mind, it's ...
This disconnect can lead to adults with cerebral palsy being prescribed medications that aren't the correct treatment for the source of their concerns, creating patterns of people taking drugs that ...
Explore integrative strategies to ease the transition off psychotropic medications, supporting detox, sleep, and nutrition ...
The North America Osteoporosis Treatment Market is experiencing robust growth, anticipated to achieve a CAGR of 7.5% from 2022 to 2028, as per a comprehensive study by Report Ocean, a leading ...
Novo Nordisk's stocks face YTD struggles due to trial results and tariffs, but strong fundamentals and outlook justify a Buy.
The Supreme Court will hear arguments on Monday challenging the constitutionality of a provision in the Affordable Care Act ...
The Parkinson’s Foundation estimates that 1 million Americans live with Parkinson’s disease, a neurodegenerative disorder.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results